Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 47,000 full-time employees.  Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. The company is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD).

Eli Lilly & Co. terlibat dalam penemuan, pengembangan, pembuatan, dan penjualan produk farmasi. Perusahaan ini berkantor pusat di Indianapolis, Indiana dan saat ini mempekerjakan 47.000 karyawan penuh waktu. Produk kesehatan kardiometaboliknya meliputi Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, dan lainnya; Humulin, Humulin 70/30, dan lainnya; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, dan VERVE-301. Produk onkologi-nya termasuk Cyramza, Erbitux, Tyvyt, dan Verzenio. Produk imunologinya meliputi Ebglyss, Olumiant, Omvoh, dan Taltz. Produk neuro ilmiah-nya termasuk Emgality dan Kisunla. Perusahaan ini, melalui anak perusahaannya, POINT Biopharma Global Inc., terlibat dalam penemuan, pengembangan, dan upaya pembuatan radiopharmaceutical, serta terapi radioligand klinis dan pra-klinis yang sedang dikembangkan untuk pengobatan kanker. Perusahaan ini juga sedang mengembangkan penghambat molekul kecil oral a4b7 integrin untuk penyakit radang usus (IBD).

Eli Lilly

NVIDIA

Microsoft

Apple

Google

Amazon

Meta Platforms

Broadcom

Taiwan Semiconductor

Tesla

Berkshire Hathaway

JPMorgan

Oracle

Walmart

Visa

MasterCard

Netflix

Exxon Mobil

SPDR S&P500 ETF

Costco

Johnson & Johnson

Home Depot

Palantir

AbbVie

Bank of America

Alibaba

Procter & Gamble

ASML

UnitedHealth Group

Chevron

Vanguard Total Stock Market ETF

General Electric

Coca-Cola

T-Mobile

Cisco

Wells Fargo

Philip Morris

Toyota

AstraZeneca

Morgan Stanley

Novo Nordisk

Novartis

Goldman Sachs

Abbott

Salesforce

American Express

Linde PLC

Blackstone

McDonald's

AT&T

Raytheon Technologies

Disney

Shell

Merck

Royal Bank of Canada

Caterpillar

Invesco QQQ Trust

Uber

PepsiCo

ServiceNow

Shopify

Verizon

Citigroup

Intuit

Booking Holdings

Micron Technology

Arista Networks

Sony

QUALCOMM

BlackRock

Charles Schwab

S&P Global

Texas Instruments

Boeing

Intuitive Surgical

Unilever

Lowe's

Boston Scientific

Banco Santander

Amgen

Accenture

Adobe

Lam Research

NextEra Energy

Progressive

Spotify

Capital One

Gilead Sciences

Danaher

Pfizer

Honeywell

Applied Materials

TotalEnergies

Palo Alto Networks

Saham Eli Lilly

Tentang Eli Lilly

Statistik Kunci